Israel’s BrainStorm gets U.S. patent for stem cell technology | Reuters – Reuters
ReutersPending approval from the U.S. Food & Drug Administration, the company is preparing for its upcoming mid-stage Phase II trial in the United States with its NurOwn adult stem cell therapy. BrainStorm is developing NurOwn for the treatment of amyotrophic …Israel’s BrainStorm gets US patent for stem cell technologyYahoo News all 23 news articles …read … Continue reading
